<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    16452102
   </pmid>
   <datecreated>
    <year>
     2006
    </year>
    <month>
     02
    </month>
    <day>
     24
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2006
    </year>
    <month>
     03
    </month>
    <day>
     02
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print-Electronic">
    <journal>
     <issn issntype="Electronic">
      1468-5833
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       332
      </volume>
      <issue>
       7539
      </issue>
      <pubdate>
       <year>
        2006
       </year>
       <month>
        Feb
       </month>
       <day>
        25
       </day>
      </pubdate>
     </journalissue>
     <title>
      BMJ (Clinical research ed.)
     </title>
     <isoabbreviation>
      BMJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.
    </articletitle>
    <pagination>
     <medlinepgn>
      455-9
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      To assess the potential of anticholinergic drugs as a cause of non-degenerative mild cognitive impairment in elderly people.
     </abstracttext>
     <abstracttext label="DESIGN" nlmcategory="METHODS">
      Longitudinal cohort study.
     </abstracttext>
     <abstracttext label="SETTING" nlmcategory="METHODS">
      63 randomly selected general practices in the Montpellier region of southern France.
     </abstracttext>
     <abstracttext label="PARTICIPANTS" nlmcategory="METHODS">
      372 people aged &gt; 60 years without dementia at recruitment.
     </abstracttext>
     <abstracttext label="MAIN OUTCOME MEASURES" nlmcategory="METHODS">
      Anticholinergic burden from drug use, cognitive examination, and neurological assessment.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      9.2% of subjects continuously used anticholinergic drugs during the year before cognitive assessment. Compared with non-users, they had poorer performance on reaction time, attention, delayed non-verbal memory, narrative recall, visuospatial construction, and language tasks but not on tasks of reasoning, immediate and delayed recall of wordlists, and implicit memory. Eighty per cent of the continuous users were classified as having mild cognitive impairment compared with 35% of non-users, and anticholinergic drug use was a strong predictor of mild cognitive impairment (odds ratio 5.12, P = 0.001). No difference was found between users and non-users in risk of developing dementia at follow-up after eight years.
     </abstracttext>
     <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
      Elderly people taking anticholinergic drugs had significant deficits in cognitive functioning and were highly likely to be classified as mildly cognitively impaired, although not at increased risk for dementia. Doctors should assess current use of anticholinergic drugs in elderly people with mild cognitive impairment before considering administration of acetylcholinesterase inhibitors.
     </abstracttext>
    </abstract>
    <affiliation>
     Inserm, E361, Pathologies of the Nervous System, 34093 Montpellier, France.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Ancelin
      </lastname>
      <forename>
       Marie L
      </forename>
      <initials>
       ML
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Artero
      </lastname>
      <forename>
       Sylvaine
      </forename>
      <initials>
       S
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Portet
      </lastname>
      <forename>
       Florence
      </forename>
      <initials>
       F
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Dupuy
      </lastname>
      <forename>
       Anne-Marie
      </forename>
      <initials>
       AM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Touchon
      </lastname>
      <forename>
       Jacques
      </forename>
      <initials>
       J
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Ritchie
      </lastname>
      <forename>
       Karen
      </forename>
      <initials>
       K
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Multicenter Study
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
    </publicationtypelist>
    <articledate datetype="Electronic">
     <year>
      2006
     </year>
     <month>
      02
     </month>
     <day>
      01
     </day>
    </articledate>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     BMJ
    </medlineta>
    <nlmuniqueid>
     8900488
    </nlmuniqueid>
    <issnlinking>
     0959-535X
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Cholinergic Antagonists
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 1999 Mar;56(3):303-8
     </refsource>
     <pmid version="1">
      10190820
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2003 Nov 11;61(9):1179-84
     </refsource>
     <pmid version="1">
      14610117
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drugs Aging. 1999 Jul;15(1):15-28
     </refsource>
     <pmid version="1">
      10459729
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J R Soc Med. 2000 Sep;93(9):457-62
     </refsource>
     <pmid version="1">
      11089480
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2001 Jan 9;56(1):37-42
     </refsource>
     <pmid version="1">
      11148233
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):455-60
     </refsource>
     <pmid version="1">
      11756667
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int Psychogeriatr. 2002 Sep;14(3):307-10
     </refsource>
     <pmid version="1">
      12475091
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Gen Psychiatry. 2003 Feb;60(2):198-203
     </refsource>
     <pmid version="1">
      12578438
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Comput Biol. 2002;9(6):849-64
     </refsource>
     <pmid version="1">
      12614551
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Neurol. 2003 Oct;60(10):1385-9
     </refsource>
     <pmid version="1">
      14568808
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 1996 Mar;46(3):661-5
     </refsource>
     <pmid version="1">
      8618663
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drugs Aging. 1993 Jul-Aug;3(4):335-48
     </refsource>
     <pmid version="1">
      8369593
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurobiol Aging. 1980 Summer;1(1):39-43
     </refsource>
     <pmid version="1">
      7266733
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Gerontol. 1983 Jan;38(1):31-5
     </refsource>
     <pmid version="1">
      6129272
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Psychopharmacology (Berl). 1990;100(2):243-50
     </refsource>
     <pmid version="1">
      2305013
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):314-9
     </refsource>
     <pmid version="1">
      1821247
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Psychopharmacology (Berl). 1992;107(2-3):437-41
     </refsource>
     <pmid version="1">
      1615141
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neuroimage. 2005 Aug 15;27(2):387-92
     </refsource>
     <pmid version="1">
      15921933
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Intern Med. 2004 Sep;256(3):240-6
     </refsource>
     <pmid version="1">
      15324367
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Psychiatry. 1992 Oct;149(10):1393-4
     </refsource>
     <pmid version="1">
      1530077
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pharmacoepidemiol Drug Saf. 1996 May;5(3):155-64
     </refsource>
     <pmid version="1">
      15073832
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dement Geriatr Cogn Disord. 2004;17(3):196-203
     </refsource>
     <pmid version="1">
      14739544
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged, 80 and over
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Attention
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cholinergic Antagonists
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cognition Disorders
     </descriptorname>
     <qualifiername majortopicyn="Y">
      chemically induced
     </qualifiername>
     <qualifiername majortopicyn="N">
      diagnosis
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Dementia
     </descriptorname>
     <qualifiername majortopicyn="N">
      chemically induced
     </qualifiername>
     <qualifiername majortopicyn="N">
      diagnosis
     </qualifiername>
     <qualifiername majortopicyn="N">
      epidemiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Epidemiologic Methods
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N" type="Geographic">
      France
     </descriptorname>
     <qualifiername majortopicyn="N">
      epidemiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Language Disorders
     </descriptorname>
     <qualifiername majortopicyn="N">
      chemically induced
     </qualifiername>
     <qualifiername majortopicyn="N">
      epidemiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Memory Disorders
     </descriptorname>
     <qualifiername majortopicyn="N">
      chemically induced
     </qualifiername>
     <qualifiername majortopicyn="N">
      epidemiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Neuropsychological Tests
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Reaction Time
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Space Perception
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Thinking
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1382539
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="aheadofprint">
     <year>
      2006
     </year>
     <month>
      2
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2006
     </year>
     <month>
      2
     </month>
     <day>
      3
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2006
     </year>
     <month>
      3
     </month>
     <day>
      3
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2006
     </year>
     <month>
      2
     </month>
     <day>
      3
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     bmj.38740.439664.DE
    </articleid>
    <articleid idtype="doi">
     10.1136/bmj.38740.439664.DE
    </articleid>
    <articleid idtype="pubmed">
     16452102
    </articleid>
    <articleid idtype="pmc">
     PMC1382539
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

